efficacy of combined inhibition of mtor and erk/mapk pathways in treating a tuberous sclerosis complex cell model
ruifang mi a;b;jianhui ma a;dechang zhang c;limin li b;hongbing zhang a;* a department of physiology;institute of basic medical sciences and school of basic medicine;chinese academy of medical sciences and peking union medical college;beijing 100005;china b department of pathology;institute of basic medical sciences and school of basic medicine;chinese academy of medical sciences and peking union medical college;beijing 100005;china c department of pharmacology;institute of basic medical sciences and school of basic medicine;chinese academy of medical sciences and peking union medical college;beijing 100005;china
..............page:355-361
..............page:379-385
..............page:371-377
..............page:363-370
..............page:343-353
..............page:335-342
..............page:325-334